CHRS Insider Trading 2026
Coherus Oncology Inc - Executive & director stock transactions
Net Sentiment
Neutral
Insider Buys
0
Insider Sells
0
Stock Price
$1.99
No recent insider trading activity for CHRS.
Get Full CHRS Analysis
Institutional ownership, financials, and AI insights
View Full AnalysisFrequently Asked Questions
Are insiders buying or selling CHRS?
Recent insider trading data for CHRS is being updated.
What is CHRS insider trading activity?
Check back for the latest CHRS insider trading activity.
Why do insiders buy CHRS stock?
Insiders (executives, directors, major shareholders) may buy CHRS stock because they believe it's undervalued or expect positive developments. Insider buying is often seen as a bullish signal since they have deep knowledge of the company.
Why do insiders sell CHRS stock?
Insiders may sell for various reasons including diversification, personal financial needs, or as part of planned 10b5-1 trading plans. Insider selling doesn't always indicate bearish sentiment - context matters.
What is the net insider activity for CHRS?
Net insider activity data for CHRS will be available when recent transactions are reported.
How do I track CHRS insider trades?
CHRS insider trades are disclosed through SEC Form 4 filings, which must be submitted within 2 business days of the transaction. This page automatically tracks and displays the latest Form 4 filings for Coherus Oncology Inc.
What is a 10b5-1 trading plan for CHRS?
A 10b5-1 trading plan allows CHRS insiders to set up predetermined trading schedules when they don't have material non-public information. This protects executives from insider trading accusations while allowing them to diversify holdings.
Is CHRS insider buying a good sign?
CHRS insider buying can be a positive signal since executives know the company intimately. However, context matters - consider the size of purchases relative to their holdings, the number of insiders buying, and whether it's open market purchases versus options exercises.